Viatris Inc VIA

XET: VIA | ISIN: US92556V1061 12/11/2024

12,19 EUR (-0,45%)

(-0,45%) 12/11/2024

Grafiek Viatris Inc

Grafiek Viatris Inc

1 dag1d -0,45%
1 week1w 1,04%
1 maand1m 17,28%
3 maanden3m 19,29%
6 maanden6m 17,33%
1 jaar1j 43,08%
5 jaar5j -19,84%

Viatris Inc in het nieuws

Toon enkel gratis nieuws

11 september 2024 · Viatris Announces Expiration and Results of Any and All Cash Tender Offers · Persbericht

10 september 2024 · Viatris Announces the Pricing Terms of Pending Any and All Cash Tender Offers · Persbericht

4 september 2024 · Viatris Announces Cash Tender Offers for Certain Outstanding Notes · Persbericht

23 augustus 2024 · Viatris Presents Late Breaking Abstract on Cenerimod at the 26th Asia-Pacific League of Associations for Rheumatology Annual Congress · Persbericht

8 augustus 2024 · Viatris Reports Second Quarter Financial Results for 2024 · Persbericht

6 augustus 2024 · Viatris Announces Second Quarter 2024 Dividend · Persbericht

3 juli 2024 · Viatris Brings to Completion All Previously Announced Divestitures With the Closing of its Over-the-Counter Business Divestiture · Persbericht

2 juli 2024 · U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation · Persbericht

25 juni 2024 · Viatris Named to TIME's World's Most Sustainable Companies 2024 List · Persbericht

7 juni 2024 · Viatris to Report Second Quarter 2024 Financial Results on August 8, 2024 · Persbericht

Profiel Viatris Inc

Gezondheidstechnologie

CEO: Michael Goettler

Werknemers: 12.348

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe